Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

RNN Rexahn Pharmaceuticals, Inc.

5.24

0.00 (0.00%)

Jul 01 2024 - Closed

Delayed by 15 minutes

Rexahn Awarded Patent in Europe for Cancer Drug Archexin®

Company to initiate Phase IIa clinical trials in Q4 of 2013

Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Rexahn Pharmaceuticals, Inc. Charts.

Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Rexahn Pharmaceuticals, Inc. Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Rexahn Pharmaceuticals, Inc. News

More Rexahn Pharmaceuticals, Inc. News Articles

New Momentum (PK)

Cann American (CE)

RespireRx Pharmaceuticals (PK)

Therapeutic Solutions (PK)

Elite Pharmaceuticals (QB)

Rennova Health (PK)

Asia Broadband (PK)

Bell Buckle (PK)

Progressive Care (QB)

Gold and GemStone Mining (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions